GlassScriptPhysician profile
Jennifer Aboagye
NPI 1609669621
$968.88
in general payments reported to CMS, 2019-2025
13 companies · $969 in 2025
The $969 reported for 2025 was more than what 84% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $390.44 | 2025 | |
| Janssen Biotech, INC. | $140.26 | 2025 | Tremfya, Stelara, Simponi Aria |
| Madrigal Pharmaceuticals | $87.88 | 2025 | Rezdiffra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.86 | 2025 | Xifaxan |
| Qol Medical, LLC | $52.77 | 2025 | Sucraid |
| Takeda Pharmaceuticals U.S.A., INC. | $48.67 | 2025 | Entyvio |
| Celltrion USA INC. | $39.51 | 2025 | Vegzelma |
| Ardelyx, INC. | $31.82 | 2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $25.01 | 2025 | Voquezna |
| Ipsen Biopharmaceuticals, INC | $20.16 | 2025 | Iqirvo |
| Genzyme Corporation | $19.00 | 2025 | |
| Organon LLC | $15.86 | 2025 | Renflexis, Hadlima |
| Aimmune Therapeutics, INC. | $13.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Aboagye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.